Boundless Bio Inc./$BOLD
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Boundless Bio Inc.
Boundless Bio Inc is a clinical-stage oncology company. It is focused on developing cancer therapeutics that address the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Using its proprietary Spyglass platform, the company identifies targets essential for ecDNA functionality, then designs and develops small-molecule drugs called ecDNA-directed therapies (ecDTx) to inhibit those targets. Its main ecDTx candidate under development, BBI-940, is a novel, oral, selective degrader that has demonstrated potent anti-tumor activity across a range of cancer cell lines and mouse xenograft models, including single-agent tumor regressions.
Ticker
$BOLD
Sector
Primary listing
Employees
28
Headquarters
Website
BOLD Metrics
BasicAdvanced
$33m
-
-$2.60
-
-
Price and volume
Market cap
$33m
52-week high
$1.78
52-week low
$0.96
Average daily volume
341k
Financial strength
Current ratio
8.743
Quick ratio
8.581
Long term debt to equity
46.494
Total debt to equity
49.704
Profitability
EBITDA (TTM)
-62.301
Management effectiveness
Return on assets (TTM)
-21.86%
Return on equity (TTM)
-46.69%
Valuation
Price to book
0.33
Price to tangible book (TTM)
0.33
Price to free cash flow (TTM)
-0.692
Free cash flow yield (TTM)
-144.60%
Free cash flow per share (TTM)
-2.111
Growth
Earnings per share change (TTM)
-32.37%
3-year earnings per share growth (CAGR)
-60.37%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Boundless Bio Inc. stock?
Boundless Bio Inc. (BOLD) has a market cap of $33M as of May 01, 2026.
What is the P/E ratio for Boundless Bio Inc. stock?
The price to earnings (P/E) ratio for Boundless Bio Inc. (BOLD) stock is 0 as of May 01, 2026.
Does Boundless Bio Inc. stock pay dividends?
No, Boundless Bio Inc. (BOLD) stock does not pay dividends to its shareholders as of May 01, 2026.
When is the next Boundless Bio Inc. dividend payment date?
Boundless Bio Inc. (BOLD) stock does not pay dividends to its shareholders.
What is the beta indicator for Boundless Bio Inc.?
Boundless Bio Inc. (BOLD) does not currently have a Beta indicator.